Response after Infection-Associated Rise in Clozapine Levels in Treatment-Resistant Schizoaffective Disorder
The clinical management of patients with treatment-resistant psychotic disorders is still challenging despite years of extensive research. If first-line antipsychotic treatment proves ineffective, clozapine is considered golden standard. Herein, we report on a patient with schizoaffective disorder t...
Main Authors: | Nina H. Grootendorst-van Mil, Anna R. M. Huiskens, Sieds Dieleman, Tom K. Birkenhäger |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Case Reports in Psychiatry |
Online Access: | http://dx.doi.org/10.1155/2018/3174368 |
Similar Items
-
Combining ECT and clozapine in the treatment of clozapine-refractory schizophrenia and schizoaffective disorder – a pilot study
by: L Koen, et al.
Published: (2008-12-01) -
Amisulpride as adjunct to clozapine in treatment-resistant schizophrenia and schizoaffective disoder: An open-label pilot study
by: Liezl Koen, et al.
Published: (2006-03-01) -
Remission structure in schizoaffective disorder
by: Olga I. Syerikova, et al.
Published: (2020-10-01) -
Neurophysiological distinction between schizophrenia and schizoaffective disorder
by: Daniel H Mathalon, et al.
Published: (2010-01-01) -
Therapy of Schizoaffective Disorder and Paranoid Schizophrenia with Episodic Course
by: L. A. Ivanova, et al.
Published: (2019-05-01)